SEE:Cordlife on target to achieve full-year net profit in FY18
The higher operating margins were also “buttressed by $2 million in government grants, as well as lower tax expense due to over-provision of taxes in prior years.
For more stories about where the money flows, click here for our Capital section
Furthermore, given the region’s slowing birth rate, he “pencilled in a 5-year revenue and PATMI CAGR of 9% and 6% due to a shift in revenue mix towards Diagnostics”. Ang added by FY2024, he expects diagnostics to form about 9% of the company’s topline.